Cargando…

Drugs in secondary stroke prevention

After an ischaemic stroke or transient ischaemic attack, patients have a high risk of having another stroke. Secondary stroke prevention includes antiplatelet therapy, statins and antihypertensives Aspirin, clopidogrel, or a combination of aspirin with dipyridamole are first-line options for seconda...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tremonti, Chris, Thieben, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236871/ https://www.ncbi.nlm.nih.gov/pubmed/34211246 http://dx.doi.org/10.18773/austprescr.2021.018

Ejemplares similares

Antiplatelets in Secondary Stroke Prevention
por: Shulga, Olga, et al.
Publicado: (2011)

Prescription of secondary preventive drugs after ischemic stroke: results from the Malaysian National Stroke Registry
por: Hwong, Wen Yea, et al.
Publicado: (2017)

Secondary stroke prevention: challenges and solutions
por: Esenwa, Charles, et al.
Publicado: (2015)

Stroke Secondary Prevention: Everyone’s Business
por: Lawrence, Maggie, et al.
Publicado: (2022)

Prasugrel for Secondary Prevention of Thrombotic Stroke
por: Yagita, Yoshiki
Publicado: (2023)

Systematic Development of Structured Semi-interactive Stroke Prevention Package for Secondary Stroke Prevention
por: Kate, Mahesh Pundlik, et al.
Publicado: (2020)

Deceptive Adherence to Anticoagulation in Secondary Stroke Prevention
por: Vibo, Riina, et al.
Publicado: (2022)

Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
por: Rasmussen, Lars Hvilsted, et al.
Publicado: (2012)

Effect of socioeconomic status on secondary prevention of stroke
por: Liu, Qun, et al.
Publicado: (2011)

Predictors of Adherence to Lifestyle Recommendations in Stroke Secondary Prevention
por: Lennon, Olive, et al.
Publicado: (2021)

Evaluating Feasibility of a Secondary Stroke Prevention Program
por: Hunter, Stephanie, et al.
Publicado: (2023)

A New Model for Secondary Prevention of Stroke: Transition Coaching for Stroke
por: Bushnell, Cheryl, et al.
Publicado: (2014)

Secondary prevention after ischaemic stroke: the ASPIRE-S study
por: Brewer, Linda, et al.
Publicado: (2015)

Baseline prescription and one-year persistence of secondary prevention drugs after an index stroke in Central Ghana
por: Sarfo, Fred Stephen, et al.
Publicado: (2016)

Secondary stroke prevention among stroke survivors in Riyadh city, Saudi Arabia
por: Alhusayni, Shaykhah F., et al.
Publicado: (2020)

Acute Secondary Prevention of Ischemic Stroke: Overlooked No Longer
por: Bulwa, Zachary B., et al.
Publicado: (2021)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Personalized approach to primary and secondary prevention of ischemic stroke
por: Polívka, Jiří, et al.
Publicado: (2014)

Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010)

Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke
por: Tsivgoulis, Georgios, et al.
Publicado: (2018)

Recent Advances in Primary and Secondary Prevention of Atherosclerotic Stroke
por: Tsivgoulis, Georgios, et al.
Publicado: (2018)

Utility of electronic patient records in primary care for stroke secondary prevention trials
por: Dregan, Alex, et al.
Publicado: (2011)

Sociodemographic variations in the contribution of secondary drug prevention to stroke survival at middle and older ages: cohort study
por: Raine, Rosalind, et al.
Publicado: (2009)

Patent foramen ovale and cryptogenic stroke: diagnosis and updates in secondary stroke prevention
por: Yuan, Kristy, et al.
Publicado: (2018)

Platelet aggregation inhibitors in primary and secondary prevention of ischemic stroke
por: Gorenoi, Vitali, et al.
Publicado: (2006)

Apixaban for Secondary Stroke Prevention: Coexistant Cerebral Atherosclerosis May Increase Recurrent Strokes
por: Kim, Jong S., et al.
Publicado: (2022)

Risk awareness in secondary stroke prevention: a review of the literature
por: Slark, Julia, et al.
Publicado: (2014)

Cilostazol for secondary stroke prevention: systematic review and meta-analysis
por: Tan, Choon Han, et al.
Publicado: (2021)

The Role of Lipid-Lowering Treatment in the Secondary Prevention of Ischemic Stroke
por: Tsankof, Alexandra, et al.
Publicado: (2021)

Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokes
por: Benavente, Lorena, et al.
Publicado: (2010)

Dabigatran in Secondary Stroke Prevention: Clinical Experience with 106 Patients
por: DeFelipe-Mimbrera, Alicia, et al.
Publicado: (2014)

Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention
por: Weber, Ralph, et al.
Publicado: (2010)

Comparison of Enoxaparin and Warfarin for Secondary Prevention of Cancer-Associated Stroke
por: Jang, Hyemin, et al.
Publicado: (2015)

Cilostazol for Secondary Prevention of Stroke: Should the Guidelines Perhaps Be Extended?
por: Galyfos, George, et al.
Publicado: (2017)

Erratum to: NOACs for secondary stroke prevention in patients with atrial fibrillation
Publicado: (2020)

Treatment of posterior circulation stroke: Acute management and secondary prevention
por: Markus, Hugh S, et al.
Publicado: (2022)

Medical Management of Dyslipidemia for Secondary Stroke Prevention: Narrative Review
por: Chang, Yoonkyung, et al.
Publicado: (2023)

Secondary Stroke Prevention After Ischemic Stroke in Patients with Alzheimer’s Disease and Other Dementia Disorders
por: Zupanic, Eva, et al.
Publicado: (2020)

Conservative treatment of juvenile with Chiari I malformation, syringomyelia, and scoliosis
por: Campo, Rhonda S, et al.
Publicado: (2010)

Secondary stroke prevention in atrial fibrillation: a challenge in the clinical practice
por: Tanislav, Christian, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tb0a3ol9ophgjj9c8gce4v8cqg